MaxCyte, Inc.: cashflow_financing
| Value | {"amount": 2056000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"} |
|---|---|
| Period | 2024-01-01 – 2024-12-31 |
| Status | current |
| Entity | MaxCyte, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T12:14:32.347225+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/500d51de-54e0-43a3-9c5f-7df63b1893fc
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001558370-25-002721Retrieved: 2026-08-19T12:14:32.347225+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001287098/cashflow-financing/2024-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/500d51de-54e0-43a3-9c5f-7df63b1893fc
History
- no predecessors — first report